Dea Adamsen is a Clinical Evaluation Manager at Ambu A/S since 2025. They previously held positions as a Senior Medical Writer at Oticon and an Akademiker at Statens Serum Institut, contributing expertise in medical writing and clinical evaluations. Dea's research experience includes a postdoctoral role at the Neurobiology Research Unit and a PhD in Clinical Biochemistry/Biochemical Genetics from the University of Zürich, where they focused on neurotransmitter deficiencies. Their academic foundation also includes a Master of Science from the University of Copenhagen, specializing in Biochemistry and Molecular Biology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices